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Amulticenter meta-analysis including data from 9,389 psoriasis patients and 9,477 control subjects was performed to
investigate the contribution of the deletion of genes LCE3C and LCE3B, involved in skin barrier defense, to psoriasis
susceptibility in different populations. The study confirms that the deletion of LCE3C and LCE3B is a common
genetic factor for susceptibility to psoriasis in the European populations (OROverall¼ 1.21 (1.15–1.27)), and for the first
time directly demonstrates the deletion’s association with psoriasis in the Chinese (OR¼ 1.27 (1.16–1.34)) and
Mongolian (OR¼ 2.08 (1.44–2.99)) populations. The analysis of the HLA-Cw6 locus showed significant differences in
the epistatic interaction with the LCE3C and LCE3B deletion in at least some European populations, indicating
epistatic effects between these two major genetic contributors to psoriasis. The study highlights the value of
examining genetic risk factors in multiple populations to identify genetic interactions, and indicates the need of
further studies to understand the interaction of the skin barrier and the immune system in susceptibility to psoriasis.
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INTRODUCTION
Psoriasis is a common chronic inflammatory disease of the skin
with a variable worldwide prevalence, being common in
European descent individuals and less frequent in Asian ancestry
populations (Bowcock, 2005). To date, several loci have been
underlined as psoriasis risk susceptibility factors, with PSORS1,
a major histocompatibility complex class I region on chromo-
some 6p21, being the locus with the largest effect identified to
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date (Nestle et al., 2009). Within PSORS1, the HLA-Cw06 allele
has been pinpointed as the risk variant that confers the strongest
susceptibility to psoriasis (Nair et al., 2006).
In a previous study we reported the association of the
deletion of two late cornified envelope (LCE) genes, LCE3C and
LCE3B (LCE3C_LCE3B-del), with psoriasis in 1,426 unrelated
psoriatic patients and 1,406 controls from four populations of
European ancestry. The LCE3C_LCE3B-del involves a 32.2-kb
deletion, removing genes LCE3C and LCE3B of the LCE cluster,
which is part of the epidermal differentiation complex on
chromosome 1q21.3. Association with rs4112788, a tag single-
nucleotide polymorphism (SNP) for the biallelic LCE3C_LCE3B-
del copy number variant, located 584 nucleotides downstream
of LCE3D, was also found. Interaction analysis showed epistatic
effects between the LCE3C_LCE3B-del and HLA-Cw06 allele
only in the Dutch population (de Cid et al., 2009). At the time of
publication, an independent genome-wide association scan in a
Chinese cohort also identified association of rs4112788 with the
disease, indicating a major role of the LCE locus in psoriasis
susceptibility (Zhang et al., 2009). Furthermore, this locus was
replicated in a German case–control study of psoriasis vulgaris
(Hu¨ffmeier et al., 2010a) and in a Spanish case–control study of
chronic plaque-type psoriasis vulgaris (Coto et al., 2010). Since
these initial studies in psoriasis, the LCE3C_LCE3B locus has
been evaluated in other and psoriasis-related phenotypes.
Hu¨ffmeier et al. (2010b) found no association of this locus with
susceptibility to psoriatic arthritis in the German samples,
whereas association with this phenotype has been detected in
the British and Irish (Bowes et al., 2010) and in the Spanish
(Docampo et al., 2010) patients. Finally, Bergboer et al. (2010)
have found negative association of the LCE3C_LCE3B locus
with atopic dermatitis.
The aim of this meta-analysis with individual patient data
was to further investigate the contribution of LCE3C_LCE3B-del
to psoriasis susceptibility and its possible interaction with the
PSORS1 locus. In all, 13 cohorts from 12 populations, 9 of
European ancestry (Finland, France, Germany, Ireland, Italy,
Spain, The Netherlands, United Kingdom, and United States
(US-California (US-CA) and US-Michigan (US-MI)), and 3 of
Asiatic origin (China, Mongolia, and Japan), were included in
the study (see Supplementary Methods online for sample
description). Overall, 9,389 psoriasis cases and 9,477 control
samples were analyzed for the association of LCE3C_LCE3B-del
with psoriasis. Association of rs4112788 was also investigated
in 11 of the 13 data sets included. A possible relationship
between PSORS1 and LCE3C_LCE3B-del and its tag SNP was
assessed through interaction analysis using directly typed HLA-
Cw06 when available, or rs130076, a SNP in linkage
disequilibrium with it (Asumalahti et al., 2002).
RESULTS AND DISCUSSION
Association analyses of the genotyping data confirmed that the
deletion of both LCE3C and LCE3B genes is a susceptibility
determinant for psoriasis in the European ancestry populations,
with a significantly higher frequency of the LCE3C_LCE3B-del
allele in psoriatic patients compared with control individuals
(OROverall¼ 1.21 (1.15–1.27), POverall¼4.58 1013; Table 1).
As no significant evidence of heterogeneity between European
ancestry populations was observed, a combined odds ratio
(OR) was calculated under a population fixed effects model. In
addition, the estimation of an overall OR under a population
random effects model—which better accommodates potential
heterogeneity across populations of the genetic effect estimates
because of genuine differences and/or different biases—was
practically identical, which is a further indication of absence of
significant heterogeneity (Lau et al., 1997; Ioannidis et al.,
2007) (Table 1 and Figure 1). At the genotype level, the analysis
suggests a potential dosage effect with genotypes having
two copies of genes LCE3C and LCE3B being a protective
factor against the development of the disease in the European
ancestry populations (OROverall¼1.20 (1.15–1.28), POverall¼
1.421013; Supplementary Table S1 online).
Genotyping of Asian population samples for the LCE3C_
LCE3B-del confirmed that the strong genetic association with
SNPs at the LCE3 genes detected in the Chinese population
(Zhang et al., 2009) is because of the presence of the deletion of
LCE3C and LCE3B. Genotyping for LCE3C_LCE3B-del in the
other Asian populations further confirmed its presence in these
populations. The deletion has the same sequence structure as
that found in Caucasian populations. The detection of significant
heterogeneity among the Asiatic population for LCE3C_LCE3B-
del allelic frequencies impeded the estimation of the overall
association of LCE3C_LCE3B-del with the psoriatic phenotype in
Asian ancestry populations. The deletion is strongly associated
with psoriasis in the Chinese and Mongolian populations
with regard to both the allelic (OR¼ 1.27 (1.16–1.34),
P¼ 1.70 1007; OR¼2.08 (1.44–2.99), P¼ 8.161005,
respectively) and the genotype level (OR¼ 1.28 (1.16–1.41),
P¼ 1.41 1007; OR¼2.04 (1.41–2.94), P¼ 9.381005,
respectively) (Supplementary Table S1 online). In the Japanese
population, however, the higher frequency of the deleted allele
among the psoriatic individuals compared with controls did not
reach the level of significance (P¼0.063; Table 1).
An analysis of rs4112788 showed association of allele C
with the disease in the European ancestry populations
(OROverall¼ 1.21 (1.15–1.27), POverall¼1.42 1012; Table 1
and Figure 1) as well as in the Chinese population (OR¼1.34
(1.21–1.46), P¼ 6.421010; Table 1). At the genotype level,
a statistically significant higher risk for psoriasis was observed
in individuals homozygous for the C allele in populations
with European ancestry (OROverall¼ 1.20 (1.15–1.27),
POverall¼ 1.81 1012) as well as in China (OROverall¼1.35
(1.22–1.47), POverall¼3.621012; Supplementary Table S2
online). The high coefficient of determination measure (r2)
(over 0.85 in all populations) indicates that rs4112788 is a
close proxy of the LCE3C_LCE3B-del allele in the Chinese
population also (Table 1). This is the first direct indication that
the strong association of psoriasis with rs4112788, detected in
the initial analysis in Chinese samples (Zhang et al., 2009), is
also associated with the LCE3C_LCE3B-del allele.
Interestingly, we observed a significant negative correlation
between the frequency of LCE3C_LCE3B-del among controls
and the corresponding OR for psoriasis for the eight popula-
tions from Europe examined—the more common the risk allele,
the smaller its effect on psoriasis risk (Supplementary Figure S1
online). Allele frequency, and the correlated effect strength,
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appears to follow an approximate north–south gradient pattern.
Even though this observation could be because of sampling
error, and additional European populations would need to be
studied, a genuine significance of this phenomenon on the
genetic predisposition to psoriasis cannot be ruled out.
Direct typing of HLA-Cw06 in The Netherlands, Italy,
Japan, Mongolia, and the US samples allowed the estimation
of a potential interaction between the LCE3C_LCE3B
deletion, or its tag SNP rs4112788, with PSORS1 locus. Apart
from the already known interaction observed in the Dutch
population alone, evidence for interaction was also observed in
the US-MI data set, but not in the Italian sample. The existence
of heterogeneity among the cohorts with European ancestry
prevented the analysis of the interaction in those cohorts as a
whole. Evidence of interaction between either LCE3C_LCE3B-
del or rs4112788 with HLA-Cw06 was not observed in the
Japanese and Mongolian data sets (Table 2).
In the remaining populations, interaction with PSORS1 was
assessed through its proxy marker rs130076. No evidence for
interaction was seen with LCE3C_LCE3B-del or its tag SNP in
any of the populations interrogated (Supplementary Table S3
online). To investigate whether the association of rs130076
with psoriasis (Supplementary Table S4 online) is independent
or secondary toHLA-Cw06, the effect of this SNP was analyzed
in a stratified analysis that defined strata by carriage of
HLA-Cw06 in the Italian data set (as the Italian was the







(del vs. intact) P-value Allele C Allele T HWE
OR (95% CI)
(C vs. T) P-value r2
Spain Control 420 (55.0) 344 (45.0) 0.10 1.49 (1.15–1.93) 0.00284 427 (55.9) 337 (44.1) 0.67 1.57 (1.21–2.05) 0.00079 0.92
Psor 227 (64.5) 125 (35.5) 0.02 233 (66.6) 117 (33.4) 0.09
Italy Control 516 (57.3) 384 (42.7) 0.03 1.30 (1.08–1.58) 0.00603 510 (57.2) 382 (42.8) 0.08 1.39 (1.15–1.68) 0.00079 0.93
Psor 573 (63.7) 327 (36.3) 0.48 583 (64.9) 315 (35.1) 1.00
France Control 211 (64.3) 117 (35.7) 0.08 1.26 (0.90–1.77) 0.1767 216 (65.1) 116 (34.9) 0.06 1.29 (0.99–1.95) 0.1405 0.96
Psor 196 (69.5) 86 (30.5) 1.00 202 (70.6) 84 (29.4) 1.00
The Netherlands Control 334 (59.6) 226 (40.4) 0.54 1.50 (1.14–1.96) 0.00329 333 (59.9) 223 (40.1) 0.62 1.54 (1.18–2.02) 0.00155 0.99
Psor 281 (68.9) 127 (31.1) 0.63 278 (68.8) 126 (31.2) 0.74
Germany Control 1,215 (64.9) 657 (35.1) 0.67 1.31 (1.15–1.48) 3.03e-05 1,151 (64.7) 627 (35.3) 0.56 1.22 (1.07–1.38) 0.00229 0.94
Psor 1,899 (70.8) 785 (29.2) 0.43 1,799 (69.1) 803 (30.9) 0.47
UK Control 1,370 (67.1) 672 (32.9) 0.94 1.16 (1.01–1.33) 0.0306 1,303 (66.4) 659 (33.4) 0.57 1.12 (0.98–1.28) 0.0872 0.86
Psor 1,323 (70.3) 559 (29.7) 0.10 1,390 (68.9) 626 (31.1) 0.30
Ireland Control 1,311 (69.2) 583 (30.8) 0.17 1.07 (0.89–1.29) 0.459 1,335 (68.8) 605 (31.2) 0.33 1.18 (0.99–1.41) 0.0695 0.94
Psor 554 (70.7) 230 (29.3) 0.90 624 (72.2) 240 (27.8) 0.47
Finland Control 436 (65.1) 234 (34.9) 0.05 1.37 (1.01–1.87) 0.046 433 (65.6) 227 (34.3) 0.09 1.37 (1.00–1.88) 0.0512 0.98
Psor 194 (71.9) 76 (28.1) 0.39 188 (72.3) 72 (27.7) 0.19
US-CA Control 378 (64.3) 210 (37.7) 0.04 1.36 (1.11–1.68) 0.00378 379 (64.0) 213 (36.0) 0.13 1.37 (1.11–1.69) 0.00339 0.95
Psor 847 (71.1) 345 (28.9) 0.09 835 (70.9) 343 (29.1) 0.06
US-MI Control 2,478 (64.8) 1,348 (35.2) 0.52 1.09 (1.00–1.20) 0.0584 2,472 (65.0) 1332 (35.0) 0.45 1.10 (1.00–1.20) 0.0515 0.98
Psor 2,835 (66.8) 1,411 (33.2) 0.33 2,828 (67.0) 1,390 (33.0) 0.46
Overall1 Control 6,028 (64.2) 3,364 (35.8) — 1.21 (1.15–1.27)2 4.58e–132 6,087 (64.2) 3,389 (35.8) — 1.21 (1.15–1.27)2 1.42e–122 —
Psor 5,902 (69.6) 2,580 (30.4) — 1.21 (1.15–1.28)3 1.47e–123 6,132 (69.2) 2,726 (30.8) — 1.21 (1.15–1.28)3 1.44e–123
China Control 2,174 (57.3) 1,620 (42.7) 0.95 1.27 (1.16–1.34) 1.70e–07 2,173 (57.6) 1,601 (42.4) 1.0 1.34 (1.21–1.46) 6.42e–10 0.91
Psor 2,518 (63.1) 1,472 (36.9) 0.21 2,543 (64.4) 1,403 (35.6) 0.01
Japan Control 631 (58.8) 443 (41.2) 0.79 1.17 (0.99–1.40) 0.0638 ND ND — — — —
Psor 689 (62.6) 411 (37.4) 1.00
Mongolia Control 166 (49.4) 170 (50.6) 0.36 2.08 (1.44–2.99) 8.16e–05 ND ND — — — —
Psor 134 (67.0) 66 (33) 0.82
Abbreviations: CI, confidence interval; CNV, copy number variant; HWE, Hardy–Weinberg equilibrium; ND, no data available; OR, odds ratio; SNP, single-
nucleotide polymorphism; US-CA, US-California data set; US-MI: US-Michigan data set.
1Overall analyses for the European ancestry populations are computed according to a logistic model in which population was introduced as a confounding
variable (based on a 2fixed effects model and a 3random effects model) after no significant evidence of heterogeneity was detected according to the Woolf
test on homogeneity of odds ratios (P=0.0763 for LCE3C_LCE3B CNV; P=0.0553 for rs4112788). Overall values for the Asian ancestry populations are not
presented as the Woolf test on homogeneity of odds ratios showed statistical significant heterogeneity among them (P=0.02091). Predictive performance of
allele C with LCE3C_LCE3B-del is presented for each population using the coefficient of determination measure (r2).
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only population in which both rs130076 and HLA-Cw06
were genotyped). In the subset of samples that does not
contain an HLA-Cw06 allele, rs130076 was no longer
significantly associated with psoriasis (OR¼ 4.64 (2.74–7.84),
P¼ 3.611009 inHLA-Cw06-positive samples vs. OR¼ 1.05
(0.73–1.50), P¼ 0.7938 in HLA-Cw06-negative samples). This
suggests that the association of rs130076 is dependent on
HLA-Cw06, but also that this SNP is an imperfect surrogate for
HLA-Cw06, at least in the Italian population. Therefore,
although it is valid to perform interaction analyses using
rs130076, these analyses will likely have less power than those
that use directly typed HLA-Cw6. Hence, it may not be
coincidental that significant interaction was detected in two of
the five data sets with HLA-Cw06 typing, but in none of the
eight data sets with rs130076 typing. The existence of a
potential epistasis found only in the Dutch and US-MI data sets,
but in none of the remaining data sets in whichHLA-Cw06was
typed, might be because of population-specific effects, different
genetic backgrounds, or varying environmental exposures
among data sets. The fact that no interaction was observed
between LCE3C_LCE3B-del and HLA-Cw06 in the Chinese
data set is probably because of the fact that despite HLA-Cw6
being a major risk allele for psoriasis in the Chinese population,
it does not explain by itself the full linkage evidence of the
PSORS1 locus in that population (Fan et al., 2008).
In summary, we have confirmed that the deletion of genes
LCE3C and LCE3B is a common genetic factor for suscepti-
bility to psoriasis in European populations, and for the
first time directly demonstrated the deletion’s associa-
tion with psoriasis in some Asian groups. Interestingly, we
detected significant differences in the epistatic interaction of
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Figure 1. Meta-analysis of LCE3C_LCE3B-del and rs4112788 for association with psoriasis across populations of European ancestry. Panel a shows the data
for LCE3C_LCE3B-del and panel b for rs4112788. Squares show the point estimate of the odds ratio (OR) and its 95% confidence intervals (95% CIs) with
regard to genotype frequencies. Diamonds show the summary effect by fixed (Overall Fix) and random (Overall Ran) effects model. Different square sizes
represent different weights of each population.
Table 2. Genetic interaction analysis betweenHLACw06 in PSORS1 and LCE3C_LCE3B-del and its rs4112788 tag SNP
HLA-Cw061 Epistasis2
Positive vs. negative rs4112788-HLA-Cw06 LCE3C_LCE3B- HLA-Cw06
Data set OR 95% CI P-value Group OR 95% CI P-value OR 95% CI P-value
The Netherlands 3.45 2.27–5.25 2.974e-09 + 2.58 1.46–4.57 0.0160 2.60 1.47–459 0.0180
 1.15 0.83–1.60 1.17 0.84–1.63
Italy 2.5 1.86–3.36 4.994e-10 + 1.22 0.45–1.75 0.57897 1.14 0.80–1.62 0.5445
 1.38 1.09–1.76 1.30 1.03–1.64
US-MI 3.69 3.19–4.27 1.063e-75 + 1.44 1.19–1.75 0.00028 1.44 1.19–1.75 0.00027
 0.95 0.85–1.06 0.95 0.85–1.06
Japan 9.25 3.94–21.7 6.854e-11 + ND 1.09 0.23–5.08 0.9266
 ND 1.17 0.98–1.39
Mongolia 34.39 16.48–1.7 1.902e-31 + ND 1.46 0.82–2.59 0.1286
 ND 3.67 1.30–10.37
Abbreviations: CI, confidence interval; ND, no data; OR, odds ratio; SNP, single-nucleotide polymorphism; US-MI, US-Michigan data set.
1OR and 95% CI for psoriasis of directly typed HLA-Cw06 was analyzed using the carrier status definition for Cw06 allele.
2Epistasis analysis performed by logistic regression models that included an interaction term (rs4112788-HLA-Cw06 or LCE3C_LCE3B-del-HLA-Cw06);
P-values are derived from the log-likelihood ratio test between the model including both additive effects plus the interaction term against the model that only
includes additive effects. Overall values for the European and Asian ancestry populations are not presented, as significant heterogeneity based on allelic
frequencies was detected by population according to the Woolf test on homogeneity of ORs (P=0.0045 and P=0.0012, respectively).
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Dutch and US-MI samples but no interaction with other
European cohorts. This study highlights the value of examin-
ing genetic risk factors in multiple populations, and suggests
that further studies in experimental models of disease are
needed to understand the interaction of the skin barrier and
the immune system in susceptibility to psoriasis.
MATERIALS AND METHODS
Genotyping
Typing of the LCE3C_LCE3B-del copy number variant was performed by
direct PCR using a four-primer or three-primer assay as previously
described (de Cid et al., 2009), allowing the simultaneous detection of
intact and deleted alleles. Genotyping rates for LCE3C_LCE3B-del
ranged from 92.5 to 100% in all European ancestry populations and
from 97.3 to 100% in Asian populations. With regard to rs4112788,
genotyping rates ranged from 93.7 to 99.6% in the European ancestry
populations, whereas it reached 99.2% in the Chinese population. SNP
assays in Spain, Netherlands, Italy, and US-CA were genotyped as
previously described (de Cid et al., 2009). In the Ireland data set,
genotyping of SNPs was performed using competitive allele-specific PCR
at Kbiosciences (Hoddesdon, Herts, UK), and in Finnish data set using
matrix-assisted laser desorption/ionization time-of-light mass spectro-
metry (Sequenom, San Diego, CA). In the remaining populations,
genotyping of SNPs was conducted using TaqMan assays (Applied
Biosystems, Foster City, CA). HLA allele discrimination in sample
collections from The Netherlands and Italy were performed as described
(de Cid et al., 2009). In the Japanese and Mongolian cohorts, HLA typing
was conducted with LABType SSO typing test (One Lambda, Canoga
Park, CA) and LABScan 100 flow analyzer. HLA-Cw06 genotypes in the
US-MI sample were determined by genotyping seven SNPs in exons 2
and 3 of the HLA-C gene, as previously described (Nair et al., 2006).
Statistical analysis
LCE3C_LCE3B-del and SNP association analysis. Logistic
regression models assessed the genetic effect of the LCE3C_LCE3B-
del and SNPs on psoriasis risk. Calculations for genotype frequency
differences were performed by regression analysis for co-dominant,
dominant, recessive, and log-additive models. The best genetic
model was selected using the Akaike information criteria. Hetero-
geneity among populations was assessed using the Woolf test that
evaluates the homogeneity of ORs. Overall values were calculated
when the homogeneity assumption among populations was
plausible, and were adjusted by population according to a logistic
model that introduces population as a confounding variable.
Potential interaction between LCE3C_LCE3B-del or rs4112788 and
HLA-Cw06 or rs130076 was evaluated from the log-likelihood ratio
test between a model that includes both the additive effect and the
interaction term against a model that only includes additive effects.
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